TD-1607 MAD Study in Healthy Subjects

Summary

TD-1607, administered intravenously as multiple ascending doses, will be investigated in healthy subjects to assess its tolerability, safety, and pharmacokinetics.

Timeline

Start

2013-10

Primary completion

2014-06

Completion

2014-07

Drugs

Indications